Ghosh, NandiniDas, AmitavaBiswas, NirupamGnyawali, SuryaSingh, KanhaiyaGorain, MahadeoPolcyn, CarlyKhanna, SavitaRoy, SashwatiSen, Chandan K.2021-10-222021-10-222020-11-11Ghosh, N., Das, A., Biswas, N., Gnyawali, S., Singh, K., Gorain, M., Polcyn, C., Khanna, S., Roy, S., & Sen, C. K. (2020). Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD+ and SIRT1. Scientific Reports, 10(1), 20184. https://doi.org/10.1038/s41598-020-76564-72045-2322https://hdl.handle.net/1805/26854Urolithin A (UA) is a natural compound that is known to improve muscle function. In this work we sought to evaluate the effect of UA on muscle angiogenesis and identify the underlying molecular mechanisms. C57BL/6 mice were administered with UA (10 mg/body weight) for 12–16 weeks. ATP levels and NAD+ levels were measured using in vivo 31P NMR and HPLC, respectively. UA significantly increased ATP and NAD+ levels in mice skeletal muscle. Unbiased transcriptomics analysis followed by Ingenuity Pathway Analysis (IPA) revealed upregulation of angiogenic pathways upon UA supplementation in murine muscle. The expression of the differentially regulated genes were validated using quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). Angiogenic markers such as VEGFA and CDH5 which were blunted in skeletal muscles of 28 week old mice were found to be upregulated upon UA supplementation. Such augmentation of skeletal muscle vascularization was found to be bolstered via Silent information regulator 1 (SIRT1) and peroxisome proliferator-activated receptor-gamma coactivator-1-alpha (PGC-1α) pathway. Inhibition of SIRT1 by selisistat EX527 blunted UA-induced angiogenic markers in C2C12 cells. Thus this work provides maiden evidence demonstrating that UA supplementation bolsters skeletal muscle ATP and NAD+ levels causing upregulated angiogenic pathways via a SIRT1-PGC-1α pathway.en-USAgeingAngiogenesisSenescenceTranscriptomicsArticle